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Introduction: Fragile-X syndrome is the most common form of intellectual disability in the general 
population, usually caused by an expansion of a trinucleotide CGG repeat in the 5’ untranslated region 
of the FMR1 gene. In most cases, expansions over 200 repeats, termed full mutations, cause silencing of 
FMR1 gene due to methylation of its promoter, and consequently loss of protein product. Expansions 
with 55-199 CGG repeats called pre-mutations or others even smaller (45-54 CGG repeats) named 
intermediate, do not cause Fragile-X syndrome, but are frequently associated with late-onset 
neurological and/or reproductive disorders (FXTAS/FXPOI). Southern Blot is still considered the gold 
standard for molecular diagnosis of Fragile-X syndrome, because it is able to clearly characterize size and 
methylation status of full and pre-mutated FMR1 alleles (following DNA digestion with methylation 
sensitive enzymes).  Nevertheless, Southern Blot is a very time-consuming technique and requires a 
large amount of intact and high-molecular weight DNA. As such, several methodologies have been 
developed to replace Southern Blot and overcome its disadvantages. 
Purpose and methods: The aim of this work was to test other techniques in order to substitute totally or 
partially the Southern Blot method, by comparing their capability for FMR1 allele sizing as well as FMR1 
Methylation status determination. The techniques/kits under investigation are based on PCR, Triplet-
Primed PCR and High Resolution Melting Curve Analysis. For this study several DNA samples from 
patients previously characterized at the molecular level in our laboratory were used.  
Although using a very small number of samples, this work describes and compares several different 
methodologies in an attempt to establish if they can adequately replace Southern Blot. 
Results and conclusions: Our results show that the Amplidex
®
 FMR1 mPCR approach is promising in 
getting away from Southern Blots applied in Fragile-X testing. 
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